Chloroquine and Hydroxychloroquine Toxicity
Open Access
- 28 May 2020
- journal article
- Published by Scientific Scholar in American Journal of Ophthalmic Clinical Trials
Abstract
Chloroquine and hydroxychloroquine have been used for decades as antimalarials and also as immunomodulating therapies for rheumatic diseases such as systemic lupus erythematosus and rheumatoid arthritis. They also have antiviral properties and are currently used empirically for the treatment of coronavirus disease 2019 (COVID-19). Retinal toxicity is a potential complication of these medications. Current ophthalmic screening and dosing recommendations aim to decrease the risk of developing retinopathy or prevent its progression. Baseline fundus examination is not currently recommended before initiating chloroquine or hydroxychloroquine for COVID-19 due to presumed very low risk of retinal toxicity. However, doses of the drugs used for the treatment of COVID-19 exceed the recommended doses, and patients often have additional risk factors. Research in the future is warranted to confirm the risk and incidence of toxicity with this novel use.Keywords
This publication has 32 references indexed in Scilit:
- Humphrey visual field findings in hydroxychloroquine toxicityEye, 2011
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and ImidazoquinolinesThe Journal of Immunology, 2011
- Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine RetinopathyOphthalmology, 2011
- Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the “flying saucer” sign)Clinical Ophthalmology, 2010
- Quinolines and structurally related heterocycles as antimalarialsEuropean Journal of Medicinal Chemistry, 2010
- Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescenceBritish Journal of Ophthalmology, 2009
- Detection of Early Hydroxychloroquine Retinal Toxicity Enhanced by Ring Ratio Analysis of Multifocal ElectroretinographyAmerican Journal of Ophthalmology, 2007
- Fundus Autofluorescence and mfERG for Early Detection of Retinal Alterations in Patients Using Chloroquine/HydroxychloroquineInvestigative Ophthalmology & Visual Science, 2006
- Fe(III)-Coordination Properties of Neuromelanin Components: 5,6-Dihydroxyindole and 5,6-Dihydroxyindole-2-carboxylic AcidInorganic Chemistry, 2006
- Detection of color vision defects in chloroquine retinopathyOphthalmology, 1999